The Form 4 filing, an SEC report of insider stock trades, was filed on November 2, 2026. It covers a sale made on October 29, 2026. Stephen P. Ewald serves as Medpace Holdings' general counsel and corporate secretary.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-29 |
| Date of Latest Transaction | 2026-10-29 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 1,245 |
| Price | $690.00 |
| Total Transaction Value | $859,050.00 |
| Insider | |
| Ticker Symbol | MEDP |
| Company | Medpace Holdings, Inc. |
| Insider Name | EWALD STEPHEN P |
| Insider Title | General Counsel & Corp. Secy |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 19,098 |
| Position Size Change | 6.12% |
| Filing | |
| Filing Date | 2026-11-02 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a stock sale, marked with transaction code S. Stephen P. Ewald sold 1,245 MEDP shares in one reported transaction. The available details do not say whether it was an open-market or private sale.
What was the average price of the transaction?
The average sale price was $690.00 per share. That price applies to the 1,245 shares sold on October 29, 2026.
How did this transaction affect the insider's holdings?
He sold 1,245 shares and reported owning 19,098 shares afterward. Adding those figures puts his reported share count before the sale at 20,343. The sale represented 6.12% of that earlier balance.
What's the total transaction value?
The total transaction value was $859,050.00. That amount covers the single reported sale of 1,245 shares at $690.00 each.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement. Footnote text was not provided, so any further explanation of the sale's terms remains unknown. The information also does not state a reason for selling.
For research purposes only; not investment advice.